FDA Approves New Drug For Rheumatoid Arthritis
Links shared publicly online about this topic.
- 1,461total visits
FDA Approves New Drug For Rheumatoid Arthritis
View full resource at medicalnewstoday.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug, FDA, Actemra
Most Recently Shared on January 12, 2010 at 4:08 pm By:
FDA Approves New Drug For Rheumatoid Arthritis http://mnt.to/3wbv
New FDA approved drug to treat infants with respiratory distress syndrome
news-medical.net — “Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.” View full resource at news-medical.net
Most Recently Shared on March 7, 2012 at 6:35 pm By:
Arthritis News: New FDA approved drug to treat infants with respiratory distress syndrome: Scientific advances a... http://t.co/YLuUBhjg
Drug halts organ damage in inflammatory genetic disorder, study suggests
sciencedaily.com — “A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease. This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage.” View full resource at sciencedaily.com
Most Recently Shared on February 11, 2012 at 6:35 pm By:
Science Daily: Drug halts organ damage in inflammatory genetic disorder, study suggests http://t.co/qLbwP7km Full http://t.co/xwlHZeT9
FDA to Review Pfizer Inc Rheumatoid Arthritis Drug
biospace.com — “NEW YORK, Dec 20, 2011 -- Pfizer Inc. /quotes/zigman/238207/quotes/nls/pfe PFE +1.04% announced today that the U.S. Food and Drug Administration has” View full resource at biospace.com
Most Recently Shared on December 24, 2011 at 6:33 pm By:
FDA to Review Pfizer Inc Rheumatoid Arthritis Drug http://t.co/FGnesrQI
FDA accepts application for Pfizer arthritis drug - seattlepi.com
seattlepi.com — “NEW YORK (AP) — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.” View full resource at seattlepi.com
Most Recently Shared on December 21, 2011 at 3:12 am By:
Dr OP Garg Doctor, Internist, Rheumatologist, and Physician
Dear friends, New hope for RA patients especially those not responding to the presently available drugs. New drug... http://t.co/K8zAKvf4
Pfizer: FDA, other countries reviewing application for new type of rheumatoid arthritis drug - The Washington Post
washingtonpost.com — “NEW YORK — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.” View full resource at washingtonpost.com
Most Recently Shared on December 20, 2011 at 9:01 pm By:
Pfizer: FDA, other countries reviewing application for new type of rheumatoid arthritis drug: NEW YORK — Drugmak... http://t.co/b0OypJhA
FDA accepts application for Pfizer arthritis drug - WSJ.com
online.wsj.com — “NEW YORK — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.” View full resource at online.wsj.com
Most Recently Shared on December 20, 2011 at 8:51 pm By:
FDA accepts application for Pfizer arthritis drug http://t.co/4VTR5V2W
FDA accepts application for Pfizer arthritis drug - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.The FDA says it expects ...” View full resource at finance.yahoo.com
Most Recently Shared on December 20, 2011 at 8:13 pm By:
Arthritis OW OW Health and Active Health Library
FDA accepts application for Pfizer arthritis drug: Drugmaker Pfizer Inc. says the Food and Drug Administration h... http://t.co/O9hWize9
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis - News Press Release | PharmiWeb.com
pharmiweb.com — “Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis - News Press Release | PharmiWeb.com” View full resource at pharmiweb.com
Most Recently Shared on December 20, 2011 at 2:59 pm By:
Press Release: Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accep... http://t.co/humdK9Bx
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Pfizer Inc. announced today that the U.S. Food and Drug Administration has accepted for review the New Drug Application for tofacitinib , an investigational novel, oral JAK inhibitor being studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis .” View full resource at finance.yahoo.com
Most Recently Shared on December 20, 2011 at 2:12 pm By:
Arthritis OW OW Health and Active Health Library
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moder... http://t.co/ufC2Qxa6
NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome
medicalnewstoday.com — “A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a ra” View full resource at medicalnewstoday.com
Most Recently Shared on September 6, 2011 at 7:05 am By:
MNT Cervical Cancer Health News
NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome http://mnt.to/3Zqx #cervicalcancer #hpv
Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis
news-medical.net — “Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has received the new drug approval from the State Food and Drug Administration for Iremod.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 2:22 pm By:
Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis: Simcere Pharmaceutical G... http://t.co/fxXLFx4
Orencia Self Injection | RA Treatment | Arthritis Today magazine
arthritistoday.org — “Those taking Orencia, or abatacept, to treat rheumatoid arthritis will soon have the option of self-injecting the drug. From Arthritis Today magazine.” View full resource at arthritistoday.org
Most Recently Shared on August 8, 2011 at 9:25 pm By:
FDA Approves Self-Injection Form of Orencia http://bit.ly/o198RE
Abatacept Approved for Sub-Q Injection - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A formulation of the rheumatoid arthritis drug abatacept (Orencia) that patients can self-inject subcutaneously has received FDA approval, its manufacturer said.” View full resource at qualitypointtech.net
Most Recently Shared on August 2, 2011 at 4:45 pm By:
Abatacept Approved for Sub-Q Injection: (MedPage Today) -- A formulation of the rheumatoid arthritis drug abatacep... http://bit.ly/p7hlfY
Medical News: Abatacept Approved for Sub-Q Injection - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “A formulation of the rheumatoid arthritis drug abatacept (Orencia) that patients can self-inject subcutaneously has received FDA approval, its manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 2, 2011 at 4:17 pm By:
Patricia Grace Eldercare Expert
Abatacept Approved for Sub-Q Injection: (MedPage Today) -- A formulation of the rheumatoid arthritis drug abatac... http://bit.ly/nVm7Ck
Medical News: Abatacept Approved for Sub-Q Injection - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “A formulation of the rheumatoid arthritis drug abatacept (Orencia) that patients can self-inject subcutaneously has received FDA approval, its manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 2, 2011 at 4:16 pm By:
Abatacept Approved for Sub-Q Injection http://bit.ly/rkVdpL
Advertisement
